The 10th Circuit Court of Appeals said that the exclusivity deals struck between the maker of EpiPen and insurance companies didn't shut out competition and were in consumers' best interest. (CN) — ...
Indiana is set to receive $6.25 million through a settlement with several global pharmaceutical companies accused of working together to drive up the price of EpiPen by more than 600% for customers.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results